Comparing medicines to control bleeding during burn skin grafts
Treatments studied
Part of Injuries & trauma clinical trials.
This study compares two medicines—tranexamic acid and thrombin—to see which works better to stop bleeding during a burn skin graft. If you have a small burn (10% or less of your body) that needs a thin skin graft, this trial could help find a safer, faster way to heal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your burn is from a flame or hot liquid (not chemicals or explosion).
- The burned area is 10% or less of your body (like the size of your torso and one arm).
- Any deeper burned spots are 5% or less of your body (like half your torso).
- You need a skin graft that will be very thin (1/12 inch) and small enough to be cut with tiny holes or slits.
- You can speak English or Spanish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a “microsurfaced” donor-skin graft can heal deep burn wounds (partial- or full-thickness burns) after recent injury. It may help improve healing when the burn area is large enough and not infected.
This trial tests an experimental medicine for people with small burns (10% or less of body surface). It aims to see if the treatment is safe and helps healing. The study has two phases: one for people getting skin grafts, and another for recent dermal burns.
This early-stage study tests a medication (phenylephrine) used during burn wound surgery to help control bleeding. If it works, it may make skin grafting safer and reduce how much bleeding surgeons see.
This trial tests whether mesenchymal stem cells (a type of healing cell) can help burn wounds recover better when combined with skin grafting. The goal is to improve how well the grafted skin takes and heals.
This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.
This Phase 3 trial tests whether giving tranexamic acid (a medicine that helps reduce bleeding) around the time of surgery can improve outcomes for people with invasive skin melanoma. It may help reduce surgical bleeding while keeping patients safe.
Hear when a new Burns trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.